🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
Research purposes: the research design in the late more than 2 lines TNBC p...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2024-12-06
Trial ID
NCT06878625
This study is testing a new medicine called AK112 (Yivoximab) for people wi...
Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-01
Trial ID
NCT07488572
Treatments Being Tested
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-06-15
Trial ID
NCT05313282
Fruquintinib is already the standard third-line treatment for metastatic co...
Status
Not Yet Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2025-05-01
Trial ID
NCT06470178
Purpose: This phase II clinical trial evaluates whether a combination of li...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07685535
Treatments Being Tested
Chemotherapy, immune checkpoint inhibitors, and anti-angiogenic targeted th...
Status
Not Yet Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2025-04-01
Trial ID
NCT06464601
1. To compare systemic neoadjuvant therapy (combination of immune checkpoin...
Status
Unknown
Location
Institute of hepatobiliary surgery,Southwest Hospital
Start Date
2021-11-01
Trial ID
NCT05277675
Treatments Being Tested
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested
The purpose of this open-label, dose escalation-dose expansion, Phase 1 cli...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2017-09-18
Trial ID
NCT03292783
Treatments Being Tested